Three different corporate names/addresses appear across the sources reviewed for this article, without an explanation of how they relate
It is the reason the FDA's career scientists spent months reviewing the evidence and arrived at a unanimous negative recommendation before a panel whose composition may not be positioned to weigh that evidence independently
Wegovy (semaglutide) is a GLP-1 receptor agonist that reduces appetite, slows digestion, and helps regulate blood sugar
CNN reported that poison control centers saw a nearly 1,500% increase in calls related to injectable weight loss drugs, many stemming from exactly this type of concentration confusion
Soares, Mete Emir Ozgurses, Huiping Zhao, Colin Sheehan, Fatemeh Alimohammadi, Lila D